Analysis of Clinical Characteristics and Risk Factors for Drug Resistance in Newly-Treated Patients with Pulmonary Tuberculosis Complicated with Chronic Obstructive Pulmonary Disease

被引:3
作者
Ma, Liangliang [1 ,3 ]
Gao, Maolong [2 ]
机构
[1] Beijing Geriatr Hosp, Dept Infect Dis, Beijing 100095, Peoples R China
[2] Beijing Geriatr Hosp, Dept Sci & Technol, Beijing 100095, Peoples R China
[3] Beijing Geriatr Hosp, Dept Infect Dis, 118 Wenquan Rd, Beijing 100095, Peoples R China
关键词
chronic obstructive pulmonary disease; pulmonary tuberculosis; Mycobacterium tuberculosis; drug resistance; risk factors; AIR-FLOW OBSTRUCTION; COPD; TB;
D O I
10.2147/IDR.S358121
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: To analyze the clinical characteristics and risk factors of drug resistance of newly-treated chronic obstructive pulmonary disease (COPD) complicated pulmonary tuberculosis (PTB).Methods: A total of 489 newly-treated PTB patients admitted to Beijing Geriatric hospital were retrospectively enrolled in this study. Of these, 138 patients with COPD were allocated to the study group, and the remaining 351 patients without COPD were allocated to the control group. The baseline information, clinical characteristics of PTB and drug resistance of Mycobacterium tuberculosis were compared between the two groups. Logistic regression was used to explore the correlation between drug resistance and COPD complications.Results: Patients complicated with COPD had a higher proportion of respiratory failure, cough, fever and night sweats, chest short breath, and emaciation between the study group and the control group (P<0.05). In terms of medical history, patients complicated with COPD also had a higher proportion of childhood TB history, cough, tuberculosis exposure rate, dust exposure rate, and malnutrition (P<0.05). There were significantly more patients with pulmonary cavities and a delayed diagnosis of TB in the study group than in the control group (P<0.05). The single drug resistance rates of isoniazid, ethambutol, rifampicin, pyrazinamide, and rifapentine, and drug resistance with any two or more drugs in the study group were significantly higher than those in the control group (P<0.05). Multivariate Logistic regression analysis showed that smoking, extrapulmonary tuberculosis, tuberculosis exposure history, malnutrition, pulmonary cavity, and delayed TB diagnosis were risk factors for drug resistance in newly-treated COPD complicated PTB patients.Conclusion: The symptoms of COPD complicated PTB were more serious. Smoking history, extrapulmonary tuberculosis, tubercu-losis exposure history, malnutrition, pulmonary cavity, and delayed diagnosis of tuberculosis were risk factors for TB resistance in these patients.
引用
收藏
页码:4861 / 4869
页数:9
相关论文
共 34 条
[1]   Advances in diagnosis of Tuberculosis: an update into molecular diagnosis of Mycobacterium tuberculosis [J].
Acharya, Bodhraj ;
Acharya, Ashma ;
Gautam, Sanjay ;
Ghimire, Sagar Prasad ;
Mishra, Gokul ;
Parajuli, Navin ;
Sapkota, Bishwa .
MOLECULAR BIOLOGY REPORTS, 2020, 47 (05) :4065-4075
[2]   Smoking Cessation in Tuberculosis Patients and the Risk of Tuberculosis Infection in Child Household Contacts [J].
Chu, Alexander L. ;
Lecca, Leonid W. ;
Calderon, Roger, I ;
Contreras, Carmen C. ;
Yataco, Rosa M. ;
Zhang, Zibiao ;
Becerra, Mercedes C. ;
Murray, Megan B. ;
Huang, Chuan-Chin .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (08) :1500-1506
[3]   Evaluation of the BACTEC MGIT 960 system and the resazurin microtiter assay for susceptibility testing of Mycobacterium tuberculosis to second-line drugs [J].
Gallo, Juliana Failde ;
Watanabe Pinhata, Juliana Maira ;
Saraceni, Claudia Patara ;
de Oliveir, Rosangela Siqueira .
JOURNAL OF MICROBIOLOGICAL METHODS, 2017, 139 :168-171
[4]   WHO global progress report on tuberculosis elimination [J].
Harding, Emilia .
LANCET RESPIRATORY MEDICINE, 2020, 8 (01) :19-19
[5]   Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids [J].
Huang, Tsan-Ming ;
Kuo, Kuan-Chih ;
Wang, Ya-Hui ;
Wang, Cheng-Yi ;
Lai, Chih-Cheng ;
Wang, Hao-Chien ;
Chen, Likwang ;
Yu, Chong-Jen .
BMC INFECTIOUS DISEASES, 2020, 20 (01)
[6]  
Huang YH, 2018, MED LAB SCI CLIN, V29, P21
[7]   Inhaled Corticosteroid Is Associated With an Increased Risk of TB in Patients With COPD [J].
Kim, Jung-Hyun ;
Park, Ji-Soo ;
Kim, Kyung-Ho ;
Jeong, Hye-Cheol ;
Kim, Eun-Kyung ;
Lee, Ji-Hyun .
CHEST, 2013, 143 (04) :1018-1024
[8]   Prior TB, Smoking, and Airflow Obstruction A Cross-Sectional Analysis of the Guangzhou Biobank Cohort Study [J].
Lam, Kin-bong Hubert ;
Jiang, Chao Qiang ;
Jordan, Rachel E. ;
Miller, Martin R. ;
Zhang, Wei Sen ;
Cheng, Kar Keung ;
Lam, Tai Hing ;
Adab, Peymane .
CHEST, 2010, 137 (03) :593-600
[9]   Pulmonary Tuberculosis and Delay in Anti-Tuberculous Treatment Are Important Risk Factors for Chronic Obstructive Pulmonary Disease [J].
Lee, Chih-Hsin ;
Lee, Ming-Chia ;
Lin, Hsien-Ho ;
Shu, Chin-Chung ;
Wang, Jann-Yuan ;
Lee, Li-Na ;
Chao, Kun-Mao .
PLOS ONE, 2012, 7 (05)
[10]  
Li, 2019, CHIN J CLIN RATIONAL, V12, P68